12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Sat, 11 Jul 2026 00:39:19 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Set-Cookie: UpalLiveSession=eyJpdiI6ImFJdG0yQlFKS0JoVnBGRnZvb3ZseGc9PSIsInZhbHVlIjoiYjhkcnhSSmRiMzVHXC93VzFnT1RnZEpwa3JTaktVdXVxZmVMcmg5NGNIeG9kazRBRjRmUFFcL3hnK2dBNmZaS0xDOElnd0ZzSHNvdWNYYlpsNzdCSjF4QT09IiwibWFjIjoiMjA5NjZiMzY1NmQ5YTI4YTg0NjMzMzhkZjY3MDk4OWQ4YTQyMjkxODczY2NiMzQ1YTQ0MDM3Y2I1OWQ1NzBmOSJ9; expires=Tue, 10-Jul-2029 00:39:19 GMT; Max-Age=94608000; path=/; HttpOnly [7] => X-Frame-Options: SAMEORIGIN [8] => X-Content-Type-Options: nosniff [9] => X-Xss-Protection: 1; mode=block [10] => Referrer-Policy: strict-origin-when-cross-origin [11] => Permissions-Policy: geolocation=(), microphone=(), camera=() [12] => Content-Security-Policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => X-Robots-Tag: noindex, nofollow, nosnippet, noarchive [15] => Strict-Transport-Security: max-age=31536000; includeSubDomains; preload [16] => Expires: Sun, 12 Jul 2026 00:39:19 GMT [17] => Vary: Accept-Encoding [18] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [19] => Cf-Cache-Status: DYNAMIC [20] => Speculation-Rules: "/cdn-cgi/speculation" [21] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [22] => Server-Timing: cfEdge;dur=4,cfOrigin;dur=110 [23] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=2i551p7JWa%2Bp15zwUPhuKQR3NLXuAksnPP5VsKphhQeHBEVmd4kfGfvuEhpSV%2FL1E%2B4xsf6Rcr2jVmFrUDEM1ieZK5NnnSkwEPJ%2F1FDgj1aUclfreZM%2BcZ8UqglmRwaTPnI%3D"}]} [24] => CF-RAY: a193c0196f50fde0-SIN [25] => alt-svc: h3=":443"; ma=86400 ) 789

 

 

据《泰叻报》等多家主流媒体报道，泰国公共卫生部周日召开新闻发布会透露，叻威提（Rajavithi）医院专家团队发现了可有效治疗新型冠状病毒感染肺炎（武汉肺炎）的药方，重症患者用药48小时后，检测结果为阴性。

公共卫生部指出，叻威提医院专家团队将抑制流感病毒的药物奥司他韦（Oseltamivir），与抗艾滋药物配合使用在武汉肺炎重症患者身上，12小时内患者病情明显好转，48小时内病毒检测结果就变成了阴性。

卫生部指出，曾经连续10天检测呈阳性的患者，在使用该药方后，检测结果成功转为阴性，目前患者体内已经没有新型冠状病毒。该药方见效快，病人使用后恢复也很快，这是抗击‘武汉肺炎’征程上的一个好消息。

而叻威提医院专家团队所用的两种药物，均是泰国政府制药组织（The Government Pharmaceutical Organization）自行生产的。

---

// // // //